Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 4/20 | 0.48 |
| ▸ | CA2 | P00918 | 4/20 | 0.48 |
| ▸ | CA4 | P22748 | 4/20 | 0.48 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.48 |
| ▸ | CA12 | O43570 | 3/20 | 0.48 |
| ▸ | CA3 | P07451 | 3/20 | 0.48 |
| ▸ | CA6 | P23280 | 3/20 | 0.48 |
| ▸ | CA5A | P35218 | 3/20 | 0.48 |
| ▸ | CA7 | P43166 | 3/20 | 0.48 |
| ▸ | CA9 | Q16790 | 3/20 | 0.48 |
| ▸ | CA14 | Q9ULX7 | 3/20 | 0.48 |
| ▸ | CA5B | Q9Y2D0 | 3/20 | 0.48 |
| ▸ | MAPT | P10636 | 3/20 | 0.48 |
| ▸ | MEN1 | O00255 | 3/20 | 0.48 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.48 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.48 |
| ▸ | AKR1B10 | O60218 | 2/20 | 0.48 |
| ▸ | AKR1B1 | P15121 | 2/20 | 0.48 |
| ▸ | DPP4 | P27487 | 2/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL514047 | 1.00 | CA1 (0.48) | CA1CA2CA4KDM4ECA12 | |
| SCHEMBL2434119 | 0.78 | ALDH1A1 (0.50) | CA1CA2CA4KDM4ECA12 | |
| SCHEMBL2434121 | 0.78 | ALDH1A1 (0.50) | CA1CA2CA4KDM4ECA12 | |
| SCHEMBL26080827 | 0.78 | MIF (0.59) | CA1CA2CA4KDM4ECA12 | |
| SCHEMBL942822 | 0.77 | CA1 (0.61) | CA1CA2CA4KDM4ECA12 | |
| SCHEMBL942824 | 0.77 | CA1 (0.61) | CA1CA2CA4KDM4ECA12 | |
| SCHEMBL1822107 | 0.77 | TTR (0.52) | CA1CA2CA4KDM4ECA12 | |
| SCHEMBL1822108 | 0.77 | TTR (0.52) | CA1CA2CA4KDM4ECA12 | |
| SCHEMBL2200345 | 0.77 | TYR (0.66) | MAPTMEN1CYP3A4KMT2AHSD17B10 | |
| SCHEMBL2200343 | 0.77 | TYR (0.66) | MAPTMEN1CYP3A4KMT2AHSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025081932-A1 | RETINOL DERIVATIVE OR SALT THEREOF, AS WELL AS PREPARATION METHOD THEREFOR AND USE THEREOF | 深圳市护家科技有限公司 | 2025-04-24 | — | — | WO | claimed |
| CN-119841755-A | Retinol derivative or its salt, and preparation method and application thereof | 深圳市护家科技有限公司 | 2025-04-18 | — | — | CN | claimed |
| CN-119541903-B | Method for identifying effectiveness of gastrodia elata extract in preventing and treating parkinsonism | 中国农业科学院农产品加工研究所 | 2025-06-13 | — | — | CN | disclosed |
| WO-2025081932-A1 | RETINOL DERIVATIVE OR SALT THEREOF, AS WELL AS PREPARATION METHOD THEREFOR AND USE THEREOF | 深圳市护家科技有限公司 | 2025-04-24 | — | — | WO | disclosed |
| CN-119841755-A | Retinol derivative or its salt, and preparation method and application thereof | 深圳市护家科技有限公司 | 2025-04-18 | — | — | CN | disclosed |
| CN-119541903-A | Method for identifying effectiveness of gastrodia elata extract in preventing and treating parkinsonism | 中国农业科学院农产品加工研究所 | 2025-02-28 | — | — | CN | disclosed |
| US-8993620-B2 | Cinnamic acid-based oligomers and uses thereof | VIRGINIA COMMONWEALTH UNIVERSITY (US) | 2015-03-31 | — | — | US | disclosed |
| US-20140080904-A1 | Cinnamic Acid-Based Oligomers and Uses Thereof | VIRGINIA COMMONWEALTH UNIVERSITY (US) | 2014-03-20 | — | — | US | disclosed |
| US-8613909-B2 | Cinnamic acid-based oligomers and uses thereof | VIRGINIA COMMONWEALTH UNIVERSITY (US) | 2013-12-24 | — | — | US | disclosed |
| US-20130289106-A1 | CINNAMIC ACID-BASED OLIGOMERS AND USES THEREOF | Virginia Commenwealth University (US) | 2013-10-31 | — | — | US | disclosed |
| US-8491872-B2 | Cinnamic acid-based oligomers and uses thereof | VIRGINIA COMMONWEALTH UNIVERSITY (US) | 2013-07-23 | — | — | US | disclosed |
| US-20120027691-A1 | Cinnamic Acid-Based Oligomers and Uses Thereof | VIRGINIA COMMONWEALTH UNIVERISITY | 2012-02-02 | — | — | US | disclosed |
| WO-2010027594-A2 | CINNAMIC ACID-BASED OLIGOMERS AND USES THEREOF | VIRGINIA COMMONWEALTH UNIVERSITY (US) | 2010-03-11 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140080904-A1 | Cinnamic Acid-Based Oligomers and Uses Thereof | SERPINB1, ELANE, CELA1 | CA1 2090/4885CA2 1209/4885CA4 336/4885 |
| US-20130289106-A1 | CINNAMIC ACID-BASED OLIGOMERS AND USES THEREOF | SERPINB1, ELANE, CELA1 | CA1 2090/4885CA2 1209/4885CA4 336/4885 |
| US-20120027691-A1 | Cinnamic Acid-Based Oligomers and Uses Thereof | SERPINB1, ELANE, CELA1 | CA1 2090/4885CA2 1209/4885CA4 336/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.